FM

Fort Mason Capital

North America, California, United States, San Francisco

Description

Fort Mason Capital is a private equity firm.

Investor Profile

Fort Mason Capital has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United Kingdom, United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United Kingdom (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Oncology
  • Pharmaceutical
  • Biopharma
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fort Mason Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 1
HBK Capital Management
North America, Texas, United States, Dallas
Co-Investments: 1
AW
North America, New York, United States, New York
Co-Investments: 1
MB
North America, New York, United States, New York
Co-Investments: 2
Clarion Capital Partners
North America, New York, United States, New York
Co-Investments: 1
Heights Capital Management
North America, California, United States, San Francisco
Co-Investments: 2
AI
North America, New York, United States, Greenport
Co-Investments: 1
Highbridge Capital Management
North America, New York, United States, New York
Co-Investments: 1
Bank of America Securities
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Fort Mason Capital?

EUSA Pharma

Hemel Hempstead, Hertford, United Kingdom

EUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series UnknownJun 28, 2007
Amount Raised: $9,100,000
EUSA Pharma

Hemel Hempstead, Hertford, United Kingdom

EUSA Pharma is a pharmaceutical company developing and licensing late-stage oncology, pain control, and critical care products.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series UnknownNov 7, 2006
Amount Raised: $18,600,000
Genelabs Technologies

Redwood City, California, United States

Genelabs Technologies is a biopharmaceutical company engaged in the R&D of therapeutics for the treatment of infectious diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Series UnknownJun 27, 2006
Amount Raised: $8,300,000

Find More Investors Like Fort Mason Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Fort Mason Capital | Pipeseed